Sensitivity and specificity of threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral sclerosis: A prospective study

The Lancet Neurology

Volumn 14, Issue 5, 2015, Pages 478-484

  Menon, Parvathi ^a   Geevasinga, Nimeshan ^a   Yiannikas, Con ^a   Howells, James ^b   Kiernan, Matthew C ^b   Vucic, Steve ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; MULTICENTER STUDY; MUSCLE ATROPHY; MUSCLE WEAKNESS; NEUROMUSCULAR DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TRANSCRANIAL MAGNETIC STIMULATION; AGED; BRAIN CORTEX; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; SINGLE BLIND PROCEDURE; STANDARDS;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; CEREBRAL CORTEX; FEMALE; GUIDELINES AS TOPIC; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84928056412     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(15)00014-9     Document Type: Article

References (32)

1. Kiernan MC, Vucic S, Cheah BC, et al. Amyotrophic lateral sclerosis. Lancet 2011, 377:942-955.
2. Brooks BR, Miller RG, Swash M, Munsat TL El Escorial revisited: revised criteria for thediagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000, 1:293-299. for the World Federation of Neurology Research Group on Motor Neuron Diseases.
3. de Carvalho M, Dengler R, Eisen A, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 2008, 119:497-503.
4. Chio A ISIS Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis. J Neurol 1999, 246(suppl 3):1-5.
5. Turner MR, Kiernan MC, Leigh PN, Talbot K Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol 2009, 8:94-109.
6. Brooks BR El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994, 124(suppl):96-107.
7. Costa J, Swash M, de Carvalho M Awaji criteria for the diagnosis of amyotrophic lateral sclerosis:a systematic review. Arch Neurol 2012, 69:1410-1416.
8. Boekestein WA, Kleine BU, Hageman G, Schelhaas HJ, Zwarts MJ Sensitivity and specificity of the 'Awaji' electrodiagnostic criteria for amyotrophic lateral sclerosis: retrospective comparison of the Awaji and revised El Escorial criteria for ALS. Amyotroph Lateral Scler 2010, 11:497-501.
9. de Carvalho M, Swash M Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis. Amyotroph Lateral Scler 2009, 10:53-57.
10. Douglass CP, Kandler RH, Shaw PJ, McDermott CJ An evaluation of neurophysiological criteria used in the diagnosis of motor neuron disease. J Neurol Neurosurg Psychiatry 2010, 81:646-649.
11. Higashihara M, Sonoo M, Imafuku I, et al. Fasciculation potentials in amyotrophic lateral sclerosis and the diagnostic yield of the Awaji algorithm. Muscle Nerve 2012, 45:175-182.
12. Krarup C Lower motor neuron involvement examined by quantitative electromyography in amyotrophic lateral sclerosis. Clin Neurophysiol 2011, 122:414-422.
13. Schrooten M, Smetcoren C, Robberecht W, Van Damme P Benefit of the Awaji diagnostic algorithm for amyotrophic lateral sclerosis: a prospective study. Ann Neurol 2011, 70:79-83.
14. Okita T, Nodera H, Shibuta Y, et al. Can Awaji ALS criteria provide earlier diagnosis than the revised El Escorial criteria?. J Neurol Sci 2011, 302:29-32.
15. Swash M Why are upper motor neuron signs difficult to elicit in amyotrophic lateral sclerosis?. J Neurol Neurosurg Psychiatry 2012, 83:659-662.
16. Vucic S, Ziemann U, Eisen A, Hallett M, Kiernan MC Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights. J Neurol Neurosurg Psychiatry 2013, 84:1161-1170.
17. Lemon RN What drives corticospinal output?. F1000 Biol Rep 2010, 2:51.
18. Vucic S, Howells J, Trevillion L, Kiernan MC Assessment of cortical excitability using threshold tracking techniques. Muscle Nerve 2006, 33:477-486.
19. Vucic S, Cheah BC, Yiannikas C, Kiernan MC Cortical excitability distinguishes ALS from mimic disorders. Clin Neurophysiol 2011, 122:1860-1866.
20. Bossuyt PM, Reitsma JB, Bruns DE, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem 2003, 49:7-18.
21. Cedarbaum J, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 1999, 169:13-21.
22. Turner MR, Cagnin A, Turkheimer FE, et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis 2004, 15:601-609.
23. How good is that test? II Bandolier, (accessed Dec 11, 2014). http://www.medicine.ox.ac.uk/bandolier/band27/b27-2.html.
24. Geevasinga N, Menon P, Yiannikas C, Kiernan MC, Vucic S Diagnostic utility of cortical excitability studies in amyotrophic lateral sclerosis. Eur J Neurol 2014, 21:1451-1457.
25. Vucic S, Lin CS, Cheah BC, et al. Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis. Brain 2013, 136:1361-1370.
26. Vucic S, Rothstein JD, Kiernan MC Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies. Trends Neurosci 2014, 37:433-442.
27. Noto YI, Misawa S, Kanai K, et al. Awaji ALS criteria increase the diagnostic sensitivity in patients with bulbar onset. Clin Neurophysiol 2012, 123:382-385.
28. Jang JS, Bae JS The Awaji criteria are not always superior to the previous criteria: a meta-analysis. Muscle Nerve 2015, published online Jan 16. 10.1002/mus.24575.
29. Kujirai T, Caramia MD, Rothwell JC, et al. Corticocortical inhibition in human motor cortex. J Physiol 1993, 471:501-519.
30. Nzwalo H, de Abreu D, Swash M, Pinto S, de Carvalho M Delayed diagnosis in ALS: the problem continues. J Neurol Sci 2014, 343:173-175.
31. Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 1996, 347:1425-1431.
32. Bensimon G, Lacomblez L, Delumeau JC, Bejuit R, Truffinet P, Meininger V A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis. J Neurol 2002, 249:609-615.